SS INNOVATIONS INTERNATIONAL (SSII) Fundamental Analysis & Valuation

NASDAQ:SSIIUS05453U2033

Current stock price

4.81 USD
-0.19 (-3.8%)
Last:

This SSII fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. SSII Profitability Analysis

1.1 Basic Checks

  • SSII had negative earnings in the past year.
  • In the past year SSII has reported a negative cash flow from operations.
  • SSII had negative earnings in each of the past 5 years.
  • SSII had a negative operating cash flow in each of the past 5 years.
SSII Yearly Net Income VS EBIT VS OCF VS FCFSSII Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M

1.2 Ratios

  • With a Return On Assets value of -16.34%, SSII perfoms like the industry average, outperforming 54.79% of the companies in the same industry.
  • The Return On Equity of SSII (-31.73%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -16.34%
ROE -31.73%
ROIC N/A
ROA(3y)-42.59%
ROA(5y)-104.94%
ROE(3y)-93.31%
ROE(5y)-404.3%
ROIC(3y)N/A
ROIC(5y)N/A
SSII Yearly ROA, ROE, ROICSSII Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

1.3 Margins

  • Looking at the Gross Margin, with a value of 46.00%, SSII is in line with its industry, outperforming 40.43% of the companies in the same industry.
  • The Profit Margin and Operating Margin are not available for SSII so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SSII Yearly Profit, Operating, Gross MarginsSSII Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

4

2. SSII Health Analysis

2.1 Basic Checks

  • SSII does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SSII has been increased compared to 1 year ago.
  • The number of shares outstanding for SSII has been increased compared to 5 years ago.
  • SSII has a better debt/assets ratio than last year.
SSII Yearly Shares OutstandingSSII Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M
SSII Yearly Total Debt VS Total AssetsSSII Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 15.12 indicates that SSII is not in any danger for bankruptcy at the moment.
  • SSII has a better Altman-Z score (15.12) than 92.55% of its industry peers.
  • A Debt/Equity ratio of 0.30 indicates that SSII is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.30, SSII is in line with its industry, outperforming 49.47% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 15.12
ROIC/WACCN/A
WACC8.92%
SSII Yearly LT Debt VS Equity VS FCFSSII Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 20M -20M

2.3 Liquidity

  • A Current Ratio of 1.86 indicates that SSII should not have too much problems paying its short term obligations.
  • SSII's Current ratio of 1.86 is on the low side compared to the rest of the industry. SSII is outperformed by 66.49% of its industry peers.
  • A Quick Ratio of 1.21 indicates that SSII should not have too much problems paying its short term obligations.
  • The Quick ratio of SSII (1.21) is worse than 70.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.21
SSII Yearly Current Assets VS Current LiabilitesSSII Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

1

3. SSII Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 43.09% over the past year.
  • SSII shows a strong growth in Revenue. In the last year, the Revenue has grown by 105.74%.
EPS 1Y (TTM)43.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)105.74%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SSII Yearly Revenue VS EstimatesSSII Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 10M 20M 30M 40M

0

4. SSII Valuation Analysis

4.1 Price/Earnings Ratio

  • SSII reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SSII Price Earnings VS Forward Price EarningsSSII Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SSII Per share dataSSII EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. SSII Dividend Analysis

5.1 Amount

  • SSII does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SSII Fundamentals: All Metrics, Ratios and Statistics

SS INNOVATIONS INTERNATIONAL

NASDAQ:SSII (4/6/2026, 8:09:38 PM)

4.81

-0.19 (-3.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12
Earnings (Next)04-13
Inst Owners0.44%
Inst Owner Change0%
Ins Owners74.85%
Ins Owner Change2.18%
Market Cap934.87M
Revenue(TTM)42.48M
Net Income(TTM)-12.13M
AnalystsN/A
Price TargetN/A
Short Float %0.63%
Short Ratio2.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 22
P/FCF N/A
P/OCF N/A
P/B 24.46
P/tB 24.46
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.22
BVpS0.2
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -16.34%
ROE -31.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46%
FCFM N/A
ROA(3y)-42.59%
ROA(5y)-104.94%
ROE(3y)-93.31%
ROE(5y)-404.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 340.1%
Cap/Sales 8.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.86
Quick Ratio 1.21
Altman-Z 15.12
F-Score5
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)262.89%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.51%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)105.74%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y56.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-118.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-95.13%
OCF growth 3YN/A
OCF growth 5YN/A

SS INNOVATIONS INTERNATIONAL / SSII Fundamental Analysis FAQ

What is the fundamental rating for SSII stock?

ChartMill assigns a fundamental rating of 2 / 10 to SSII.


What is the valuation status for SSII stock?

ChartMill assigns a valuation rating of 0 / 10 to SS INNOVATIONS INTERNATIONAL (SSII). This can be considered as Overvalued.


How profitable is SS INNOVATIONS INTERNATIONAL (SSII) stock?

SS INNOVATIONS INTERNATIONAL (SSII) has a profitability rating of 1 / 10.


How financially healthy is SS INNOVATIONS INTERNATIONAL?

The financial health rating of SS INNOVATIONS INTERNATIONAL (SSII) is 4 / 10.